Author:
Brandt Allison S.,Nucifora Frederick C.,Zandi Peter P.,Margolis Russell L.
Reference31 articles.
1. Racial Disparities in Clozapine Prescription Patterns Among Patients With Schizophrenia. PS appi.ps.20230226;Barry,2024
2. Clozapine REMS, 2021. Clozapine and the Risk of Neutropenia: A Guide for Healthcare Providers. https://cpmgstorageproduction.blob.core.windows.net/cpmg-public/cpmg-hpguide-clozapine-prescriber-guide%20v0_05%20clean.pdf?skoid=153f69fb-5a75-4401-8fda-28b1bd974fd0&sktid=59fc620e-de8c-4745-abcc-18182d1bf20e&skt=2024-04-25T19%3A47%3A31Z&ske=2024-05-01T19%3A52%3A31Z&sks=b&skv=2021-12-02&sv=2021-12-02&st=2021-08-10T13%3A51%3A35Z&se=2031-08-10T23%3A59%3A59Z&sr=b&sp=rc&sig=%2FSookZ4ygjZlxEsNBxEIyCGqVFpmfhqTYPvkPlkAZfs%3D (accessed 4.25.24).
3. The history of clozapine and its emergence in the US market: a review and analysis;Crilly;Hist. Psychiatry,2007
4. Ethnic minority inequalities in access to treatments for schizophrenia and schizoaffective disorders: findings from a nationally representative cross-sectional study;Das-Munshi;BMC Med.,2018
5. Ethnic inequalities in clozapine use among people with treatment-resistant schizophrenia: a retrospective cohort study using data from electronic clinical records;de Freitas;Soc. Psychiatry Psychiatr. Epidemiol.,2022